Parameters of LRP5 from a structural and molecular perspective

Critical Reviews in Eukaryotic Gene Expression

Volumn 15, Issue 3, 2005, Pages 229-242

  Johnson, Mark L ^a,b   Summerfield, Douglas T ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Bone mass; LRP5; Wnt; catenin

Indexed keywords

ARROW PROTEIN; BETA CATENIN; DROSOPHILA PROTEIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; UNCLASSIFIED DRUG; WNT PROTEIN; ARROW PROTEIN, DROSOPHILA; CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR; LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SIGNAL PEPTIDE;

BONE DISEASE; BONE MASS; DNA MODIFICATION; EYE DISEASE; GENE MUTATION; HUMAN; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; VISION; AMINO ACID SEQUENCE; ANIMAL; BONE DENSITY; CHEMISTRY; GENETICS; METABOLISM; MOUSE; MUTATION; OSTEOPOROSIS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BONE DENSITY; DROSOPHILA PROTEINS; EPIDERMAL GROWTH FACTOR; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MICE; MUTATION; OSTEOPOROSIS; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECEPTORS, LDL; REPETITIVE SEQUENCES, AMINO ACID;

EID: 33644920994     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0743-4154(05)23013-4     Document Type: Review

References (58)

1. Strickland DK, Gonias SL, Argraves WS. Diverse roles for the LDL receptor family. Trends Endocrinol Metab. 2002;13(2):66-74.
2. Nykjaer A, Willnow TE. The low-density lipoprotein receptor gene family: a cellular Swiss army knife? Trends Cell Biol. 2002;12:273-80.
3. Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J Biol Chem. 1974;249:5133-62.
4. Miller JR. The Wnts. Genome biology. 2001;3:3001.1-3001.15.
5. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev. Biol. 2004;20:781-810.
6. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene. 2004;341:19-39.
7. Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT. The Wnt/Ca+2 pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 2000;16:279-83.
8. Mlodzik M. Planar cell polarization: do the same mechanisms regulate Drosophila tissue polarity and vertebrate gastrulation? Trends Genet. 2002;18:564-71.
9. Kim DH, Inagaki Y, Suzuki T, Ioka RX, Yoshioka SZ, Magoori K, Kang MJ, Cho Y, Nakano AZ, Liu Q, Fujino T, Suzuki H, Sasano H, Yamamoto TT. A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E. Eur J Biochem. 1998;124:1072-6.
10. Dong Y, Lathrop W, Weaver D, Qiu Q, Cini J, Bertolini D, Chen D. Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. Biochem Biophys Res Commun. 1998;251:784-90.
11. Hey PJ, Twells RC, Phillips MS, Yusuke N, Brown SD, Kawaguchi Y, Cox R, Guochun X, Dugan V, Hammond H, Metzker ML, Todd JA, Hess JF. Cloning of a novel member of the low-density lipoprotein receptor family. Gene. 1998;216:103-11.
12. Brown SD, Twells RC, Hey PJ, Cox RD, Levy ER, Soderman AR, Metzker ML, Caskey CT, Todd JA, Hess JF. Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. Biochem Biophys Res Commun. 1998;248:879-88.
13. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S. Arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature. 2000;407:527-30.
14. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH-J, Glass DA, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002;157:303-14.
15. Springer TA. An extracellular β-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components. J Mol Biol. 1998;283:837-62.
16. Jeon H, Meng W, Takagi J, Eck MJ, Springer TA, Blacklow SC. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nat Struct Biol. 2001;8:499-504.
17. Rudenko G, Henry L, Henderson K, Ichtchenko K, Brown MS, Goldstein JL, Deisenhofer J. Structure of the LDL receptor extracellular domain at endosomal pH. Science. 2002;298:2353-8.
18. Takagi J, Yang Y, Liu J, Wang J, Springer T. Complex between nidogen and laminin fragments reveals a paradigmatic-propeller interface. Nature. 2003;424:969-74.
19. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002;70:11-9.
20. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arsian-Kirchner M, Batch JA, Beighton P, Black GCM, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepa A, Floege B, Halfide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superta-Furga A, Swoboda W, van den Boogaard M-J, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001;107:513-23.
21. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002;346(20):1513-21.
22. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius J, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C. Kremen proteins are Dickkopf receptors that regulate Wnt/B-catenin signalling. Nature. 2002;417:664-7.
23. Van Wesenbeeck E, Cleiren E, Gram J, Beals R, Benichou O, Scopelliti D, Key L, Renton T, Bartles C, Gong Y, Warman M, Vernejoul M, Bollerslev J, Van Hul W. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet. 2003;72:763-71.
24. Johnson ML, Harnish K, Nusse R, Van Hul W. LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res. 2004;19:1749-57.
25. Hartikka H, Makitie O, Mannikko M, Doria AS, Daneman A, Cole WG, Ala-Kokko L, Sochett EB. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res. 2005;20:783-9.
26. Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML, Williams BO. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res. 2004;19:2033-40.
27. Toomes C, Bottomley H, Jackson RM, Towns KV, Scott S, Mackey DA, Craig JE, Jiang L, Yang Z, Trembath R, Woodruff G, Gregory-Evans CY, Gregory-Evans K, Parker MJ, Black GCM, Downey LM, Zhang K, Inglehearn CF. Mutations in the LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet. 2004;74:721-30.
28. van Nouhuys CE. Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy. Am J Ophthalmol. 1991;111:34-41.
29. Streeten EA, Puffenberger E, Morton H, McBride D. Osteoporosis pseudoglioma syndrome: 4 siblings with a compound heterozygote LRP5 mutation. J Bone Miner Res. 2004;19 (Suppl 1):S182.
30. Jin LY, Lau HHL, Smith DK, Lau KS, Cheung PT, Kwan EYW, Low L, Chan V, Kung AWC. A family with osteoporosis-pseudoglioma syndrome (OPG) due to compound heterozygous mutation of the LRP5 gene. J Bone Miner Res. 2004;19 (Suppl 1):S129.
31. Ai M, Schelling D, Warman ML. OPPG and HBM disease-causing missense mutations in LRP5 have opposite effects on Wnt signaling. J Bone Miner Res. 2004;19 (Suppl 1):S80.
32. Bhat BM, Allen KM, Graham J, Liu W, Morales A, Anisowicz A, Lam H, McCauley C, Coleburn V, Cain M, Fortier W, Wang H, Bex FJ, Yaworsky P. Functional modulation of LRP5-Wnt-Dkk1 activity by various mutations in LRP5 beta-propeller 1. J Bone Miner Res. 2003;18(suppl A):S46.
33. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature. 2001;411:321-5.
34. Holmen SL, Salic A, Zylstra CR, Kirschner MW, Williams BO. A novel set of Wnt-Frizzled fusion proteins identifies receptor components that activate beta-catenin-dependent signaling. J Biol Chem. 2002;277:34727-35.
35. Schweizer L, Varmus H. Wnt/Wingless signaling through beta-catenin requires the function of both LRP/Arrow and frizzled classes of receptors. BMC Cell Biol. 2003;4(1):4.
36. Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC, Krumlauf R. Wise, a context-dependent activator and inhibitor of Wnt signaling. Development. 2003;130:4295-305.
37. Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, Zheng J, Li L, Harris S, Wu D. The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol. 2004;24:4677-84.
38. Hsieh J-C, Lee L, Zhang L, Wefer S, Brown K, Rosenquist T, Holdener BC. Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity. Cell. 2003;112:355-67.
39. Culi J, Mann RS. Boca, an endoplasmic reticulum protein required for wingless signaling and trafficking of LDL receptor family members in Drosophila. Cell. 2003;112:343-54.
40. Mao J, Wang J, Liu B, Pan W, Farr G, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D. Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical Wnt signaling pathway. Mol Cell. 2001;7:801-9.
41. Brennan K, Gonzalez-Sancho JM, Castelo-Soccio LA, Howe LR, Brown AM. Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins. Oncogene. 2004;23:4873-84.
42. Gonzalez-Sancho JM, Brennan KR, Castelo-Soccio LA, Brown AM. Wnt proteins induce dishevelled phosphorylation via an LRP5/6 independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol Cell Biol. 2004;24:4757-68.
43. Chen WJ, Goldstein JL, Brown MS. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem. 1990;265:3116-23.
44. Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, He X. A mechanism for Wnt coreceptor activation. Mol Cell. 2004;13:149-56.
45. Hay E, Fauchen C, Suc-Royer I, Touitou R, Stiot V, Vayssiere B, Baron R, Roman SR, Rawadi G. Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway. J Biol Chem. 2005;280(14):13616-23.
46. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature. 2000;407:535-8.
47. Cullen DM, Akhter MP, Mace D, Johnson ML, Babij P, Recker RR. Bone sensitivity to mechanical loads with the Lrp5 HBM mutation. J Bone Miner Res. 2002;17 (suppl 1):S332.
48. Sawakami K, Robling AG, Pitner ND, Warden SJ, Li J, Warman ML, Turner CH. Site-specific osteopenia and decreased mechanoreactivity in Lrp5-mutant mice. J Bone Miner Res. 2004;19 (Suppl 1):S38.
49. Ferrari S, Deutsch S, Choudhury U, Chevalley T, Bonjour J, Dermitzakis E, Rizzoli R, Antonarakis S. Polymorphisms in the low-density lipoprotein receptor-related protein 5(LRP5) gene are associated with variation in vertebral bone mass vertebral bone size, and stature in whites. Am J Hum Genet. 2004;74:866-75.
50. Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, Ralston SH, Compston JE, Cooper C, Keen R, Langdahl BL, MacLelland A, O'Riordan J, Pols HA, Reid DM, Uitterlinden AG, Wass JAH, Brown MA. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res. 2004;19:1619-27.
51. Jiao X, Ventruto V, Trese MT, Shastry BS, Hejtmancik JF. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. Am J Hum Genet. 2004;75:878-84.
52. de Crecchio G, Simonelli F, Nunziata G, Mazzeo S, Greco GM, Rinaldi E, Ventruto V, Ciccodicola A, Miano MG, Testa F, Curci A, D'Urso MM, Rinaldi MM, Cavaliere ML, Castellucio P. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin Genet. 1998;54:315-20.
53. Fujino T, Asaba MJ, Kang M, Ikeda Y, Sone H, Takads S, Kim D, Loka R, Ono M, Tomoyori H, Okubo M, Murase T, Kmataki A, Yamamoto J, Magoori K, Takahashi S, Miyamoto Y, Oishi H, Nose M, Okazaki M, Usui S, Imaizumi K, Yanagisawa M, Sakai J, Yamamoto T. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A. 2003;100:229-34.
54. Rickels MR, Zhang X, Mumm S, Whyte M. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation. J Bone Miner Res. 2005;20:878-85.
55. Shastry BS, Trese MT. Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity. Am J Med Genet. 1997;69:217-8.
56. Okubo M, Horinishi A, Kim DH, Yamamoto TT, Murase T. Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene. Hum Mutat. 2002;19:186-8.
57. Koh JM, Jung MH, Hong JS, Park HJ, Chang JS, Shin HD, Kim SY, Kim GS. Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J Korean Med Sci. 2004;19:407-12.
58. Mizuguchi T, Furuta I, Watanbe Y, Tsukamoto K, Tomita H, Tsujihata M, Ohta T, Kishino T, Matsumoto N, Minakami H, Niikawa N, Yoshiura K. LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J Hum Genet. 2004;49:80-6.